Skip to content

Basket

You currently have no items in your basket.

Total (excl. vat) £0.00
View basket & checkout
Proteins and Peptides

Recombinant Human TNFRSF12A/TWEAKR/CD266 Protein

Product Sizes
50 ug
£240.00
RP00166-50UG
100 ug
£353.00
RP00166-100UG
About this Product
SKU:
RP00166
Additional Names:
CD266, FN14, TWEAKR,TNFRSF12A,FN14,TWEAKR
Extra Details:
Recombinant Human TNFRSF12A/TWEAKR/CD266 Protein is produced by HEK293 expression system. The target protein is expressed with sequence (Glu28-Trp79) of human TNFRSF12A/FN14/TWEAKR (Accession #NP_057723.1) fused with an Fc, 6xHis tag at the C-terminus.
Formulation:
Lyophilized from a 0.22 um filtered solution of PBS, pH 7.4.Contact us for customized product form or formulation.
Immunogen:
Glu28-Trp79
Molecular Weight:
32.30 kDa
Physical State:
Lyophilized
Purity:
≥ 90 % as determined by SDS-PAGE;≥ 90 %
Sequence:
EQAPGTAPCSRGSSWSADLDKCMDCASCRARPHSDFCLGCAAAPPAPFRLLW
Shipping Conditions:
Blue Ice
Storage Conditions:
-20[o]C reconstituted. Avoid freeze/thaw cycles., 2-8[o]C reconstituted., -20[o]C/-70[o]C lyophilized. Avoid freeze/thaw cycles.
Supplier:
ABclonal Technology
Type:
Proteins, Peptides, Small Molecules & Other Biomolecules: Recombinant Proteins
Recombinant Human TNFRSF12A/TWEAKR/CD266 Protein was determined by SDS-PAGE under reducing conditions with Coomassie Blue.
The purity of Human TNFRSF12A/FN14/TWEAKR Protein (Cat.RP00166) was greater than 90% as determined by SEC-HPLC.
Immobilized Human TNFSF12 at 2 ug/mL (100 uL/well) can bind Human TNFRSF12A with a linear range of 0.1-2.3 ng/mL.
Recombinant Human TNFRSF12A inhibits the TWEAK-dependent proliferation of HUVEC human umbilical vein endothelial cells. The ED50 for this effect is 20-80 ng/mL in the presence of 15 ng/mL recombinant human TWEAK.